Skip to main content
. 2022 Feb 11;9:758464. doi: 10.3389/fmed.2022.758464

Table 6.

Clinically actionable mutations detected in stage 4-4B cases and their concordance of detection with tissue EGFR tests.

Stage Mutation (HGVSp) AF (%) Concordant with tissue EGFR
4B EGFR p.E746_A750del 7.15 Yes
4 EGFR p.E746_A750del 0.73 Yes
4 KRAS p.G12D 12.36 NA
4 EGFR p.L747_A750delinsP 0.98 Yes
4 BRAF p.K601E 12.45 NA
4 KRAS p.G12D 27.17 NA
4 EGFR p.E746_A750del 0.33 Yes
4 EGFR p.E746_S752delinsV 50.7 Yes
4 KRAS p.G12D 3.32 NA

NA, not applicable as not tested by tissue EGFR.